tiprankstipranks
Advertisement
Advertisement

Max Healthcare Publishes Unaudited Q3 and Nine-Month FY2025 Results

Story Highlights
  • Max Healthcare’s board approved unaudited standalone and consolidated results for Q3 and nine months FY2025.
  • The results, with unmodified auditor reviews, were published and posted online to meet SEBI disclosure norms.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Max Healthcare Publishes Unaudited Q3 and Nine-Month FY2025 Results

Meet Samuel – Your Personal Investing Prophet

Max Healthcare Institute Ltd ( (IN:MAXHEALTH) ) has issued an update.

Max Healthcare Institute Limited has announced that its Board of Directors approved the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025, at a meeting held on February 5, 2026. In line with SEBI listing regulations, the company has published these results in national and regional newspapers (Business Standard and Navshakti) and made them available on its website as well as on the NSE and BSE portals, accompanied by unmodified limited review reports from its statutory auditors, reinforcing transparency and regulatory compliance for investors and other stakeholders.

More about Max Healthcare Institute Ltd

Max Healthcare Institute Limited is a listed Indian healthcare services provider operating hospitals and related medical facilities. The company focuses on delivering clinical care and healthcare services across key urban markets, and its securities are traded on both the National Stock Exchange of India and BSE Limited under the symbol MAXHEALTH/Scrip Code 543220.

Average Trading Volume: 107,031

Technical Sentiment Signal: Hold

Current Market Cap: 998.6B INR

For a thorough assessment of MAXHEALTH stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1